Sensient director awarded deferred stock units

Director Joseph Carleone was credited with 296.253 shares of Deferred Stock, representing a grant or award tied to the deferral of director fees under Sensient Technologies’ Directors' Deferred Compensation Plan.

Rhea-AI Filing Summary

Director Joseph Carleone was credited with 296.253 shares of Deferred Stock, representing a grant or award tied to the deferral of director fees under Sensient Technologies’ Directors' Deferred Compensation Plan. This deferred stock converts into common stock on a one-for-one basis, with shares of common stock to be issued when his board service ends. Following these entries, he holds 24,163.893 shares of common stock directly, including restricted stock under the 2017 Stock Plan and shares accumulated through a dividend reinvestment plan.

Insider Trade Summary

Grant/Award: 296.253 shares

Grant/Award 2 txns

Insider Carleone Joseph

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock	296.253	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Deferred Stock — 24,163.893 contracts (Direct); Common Stock — 23,735.029 shares (Direct)

Footnotes (4)

1. F1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
2. F2. Deferred stock converts to common stock on a one-for-one basis.
3. F3. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.
4. F4. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.

Key Figures

Deferred stock grant: 296.253 shares Common shares after transaction: 24,163.893 shares Deferred stock conversion rate: 1:1 to common stock

3 metrics

Deferred stock grant 296.253 shares Director fee deferral under Directors' Deferred Compensation Plan

Common shares after transaction 24,163.893 shares Direct common stock holdings following reported entries

Deferred stock conversion rate 1:1 to common stock Deferred stock converts to common stock on a one-for-one basis

Key Terms

Deferred Stock, Directors' Deferred Compensation Plan, restricted stock, dividend reinvestment plan

4 terms

Deferred Stock financial

"Deferred stock converts to common stock on a one-for-one basis."

Directors' Deferred Compensation Plan financial

"Deferral of director fees under Issuer's Directors' Deferred Compensation Plan."

restricted stock financial

"Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated,"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

dividend reinvestment plan financial

"and shares held in a dividend reinvestment plan."

A dividend reinvestment plan lets shareholders automatically use cash dividends to buy more shares of the same company instead of receiving the money. It matters to investors because it turns regular payouts into a steady way to grow ownership and take advantage of compound returns—like having your savings automatically buy additional slices of a pie over time—while often reducing transaction costs and smoothing purchase timing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sensient Technologies (SXT) report for Joseph Carleone?

Sensient Technologies reported that director Joseph Carleone received a grant of 296.253 shares of Deferred Stock. This award reflects deferred director fees and is not an open-market stock purchase or sale, but a compensation-related acquisition.

How does the deferred stock for SXT director Joseph Carleone convert to common shares?

The filing states that Deferred stock converts to common stock on a one-for-one basis. This means each deferred stock unit will become one share of Sensient common stock when the conditions in the directors’ plan are satisfied.

When will Joseph Carleone receive common shares from his Sensient deferred stock?

According to the disclosure, shares of common stock will be issued upon termination of Joseph Carleone’s service as a director. Until that point, the award remains as deferred stock units under the company’s compensation plan.

How many Sensient Technologies shares does Joseph Carleone hold after this Form 4?

After the reported transactions, Joseph Carleone directly holds 24,163.893 shares of Sensient common stock. This total includes restricted stock granted under the 2017 Stock Plan and shares accumulated through a dividend reinvestment plan.

Is the Sensient (SXT) Form 4 a buy or sell signal for investors?

The Form 4 primarily records a grant of deferred stock tied to director fees, not an open-market buy or sell. It reflects routine board compensation, so it does not represent a typical trading signal about the director’s market view.

What plans or programs are referenced in the Sensient Technologies Form 4 for Joseph Carleone?

The filing references the 2017 Stock Plan, as amended and restated, which governs restricted stock, and the Directors' Deferred Compensation Plan, under which director fees are deferred and credited as deferred stock units convertible into common shares later.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 05:58 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carleone Joseph

(Last) (First) (Middle)

777 EAST WISCONSIN AVENUE

(Street)

MILWAUKEE WISCONSIN 53202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SENSIENT TECHNOLOGIES CORP [ SXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								23,735.029(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock	(2)	06/30/2026		A(3)		296.253		(4)	(4)	Common Stock	296.253	$0	24,163.893	D

Explanation of Responses:

1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.

2. Deferred stock converts to common stock on a one-for-one basis.

3. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.

4. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.

	/s/ John J. Manning, Attorney-in-Fact for Dr. Carleone	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)